Patents by Inventor Cynthia K. French

Cynthia K. French has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7833729
    Abstract: This invention provides a polynucleotide encoding Repro-EN-1.0 and IB1, polypeptides associated with endometriosis. Auto-antibodies against Repro-EN-1.0 and IB1 have been found in subjects diagnosed with endometriosis. This invention also provides methods of using this polynucleotide and polypeptide.
    Type: Grant
    Filed: September 22, 2009
    Date of Patent: November 16, 2010
    Assignee: Siemens Heathcare Diagnostics Inc.
    Inventors: A. Said El Shami, Surendra Nath Menon, Cynthia K. French
  • Publication number: 20100086940
    Abstract: This invention provides a polynucleotide encoding Repro-EN-1.0 and IB1, polypeptides associated with endometriosis. Auto-antibodies against Repro-EN-1.0 and IB1 have been found in subjects diagnosed with endometriosis. This invention also provides methods of using this polynucleotide and polypeptide.
    Type: Application
    Filed: September 22, 2009
    Publication date: April 8, 2010
    Inventors: A. Said El Shami, Surendra Nath Menon, Cynthia K. French
  • Patent number: 7507549
    Abstract: This invention provides cDNA encoding a prostate-cancer specific marker, Repro-PC-1.0, Repro-PC-1.0 polypeptides and methods for use in diagnosis and therapy.
    Type: Grant
    Filed: July 19, 2004
    Date of Patent: March 24, 2009
    Assignee: Siemens Healthcare Diagnostices, Inc.
    Inventors: Cynthia K. French, Karen K. Yamamoto, A. Said El Shami
  • Patent number: 7368533
    Abstract: This invention provides a polynucleotide encoding Repro-EN-1.0 and IB1, polypeptides associated with endometriosis. Auto-antibodies against Repro-EN-1.0 and IB1 have been found in subjects diagnosed with endometriosis. This invention also provides methods of using this polynucleotide and polypeptide.
    Type: Grant
    Filed: June 13, 2002
    Date of Patent: May 6, 2008
    Assignee: Siemens Medical Solutions Diagnostics
    Inventors: A. Said El Shami, Surendra Nath Menon, Cynthia K. French
  • Patent number: 6900022
    Abstract: This invention provides cDNA encoding a prostate-cancer specific marker, Repro-PC-1.0, Repro-PC-1.0 polypeptides and methods for use in diagnosis and therapy.
    Type: Grant
    Filed: October 4, 2000
    Date of Patent: May 31, 2005
    Assignee: Diagnostic Products Corporation
    Inventors: Cynthia K. French, Karen K. Yamamoto, A. Said El Shami
  • Patent number: 6753138
    Abstract: Prothymosin expression is up-regulated in endometriotic tissue. This invention provides methods of diagnosing endometriosis by detecting up-regulation of a prothymosin gene product, and methods of treating endometriosis by down-regulating expression of prothymosin in ectopic or eutopic endometriotic tissue.
    Type: Grant
    Filed: December 27, 2000
    Date of Patent: June 22, 2004
    Assignee: Reprogen, Inc.
    Inventors: Patrick A. Schneider, Cynthia K. French, Karen K. Yamamoto
  • Publication number: 20040096884
    Abstract: Prothymosin expression is up-regulated in endometriotic tissue. This invention provides methods of diagnosing endometriosis by detecting up-regulation of a prothymosin gene product, and methods of treating endometriosis by down-regulating expression of prothymosin in ectopic or eutopic endometriotic tissue.
    Type: Application
    Filed: September 2, 2003
    Publication date: May 20, 2004
    Inventors: Patrick A. Schneider, Cynthia K. French, Karen K. Yamamoto
  • Publication number: 20030083253
    Abstract: This invention provides a polynucleotide encoding Repro-EN-1.0 and IB1, polypeptides associated with endometriosis. Auto-antibodies against Repro-EN-1.0 and IB1 have been found in subjects diagnosed with endometriosis. This invention also provides methods of using this polynucleotide and polypeptide.
    Type: Application
    Filed: June 13, 2002
    Publication date: May 1, 2003
    Inventors: A. Said El Shami, Surendra Nath Menon, Cynthia K. French
  • Patent number: 6525187
    Abstract: This invention provides a polynucleotide encoding Repro-EN-1.0 and IB1, polypeptides associated with endometriosis. Auto-antibodies against Repro-EN-1.0 and IB1 have been found in subjects diagnosed with endometriosis. This invention also provides methods of using this polynucleotide and polypeptide.
    Type: Grant
    Filed: November 23, 1999
    Date of Patent: February 25, 2003
    Assignee: Diagnostic Products Corporation
    Inventors: A. Said El Shami, Surendra Nath Menon, Cynthia K. French
  • Publication number: 20030033614
    Abstract: This invention provides methods of identifying hormone-regulated traits in a cell. The methods involve cultivating the cell as a graft in two different hormonal environments and determining whether expression of the trait differs in the two grafts.
    Type: Application
    Filed: September 17, 2001
    Publication date: February 13, 2003
    Inventors: Cynthia K. French, Karen K. Yamamoto
  • Patent number: 6387629
    Abstract: Cathepsin S expression is up-regulated in endometriotic tissue. This invention provides methods of diagnosing endometriosis by detecting up-regulation of a cathepsin S gene product, and methods of treating endometriosis by down-regulating expression of cathepsin S in ectopic or eutopic endometriotic tissue.
    Type: Grant
    Filed: March 26, 2001
    Date of Patent: May 14, 2002
    Assignee: Reprogen, Inc.
    Inventors: Patrick Schneider, Karen K. Yamamoto, Cynthia K. French
  • Patent number: 6218523
    Abstract: This invention provides cDNA encoding a prostate-cancer specific marker, Repro-PC-1.0, Repro-PC-1.0 polypeptides and methods for use in diagnosis and therapy.
    Type: Grant
    Filed: March 6, 1998
    Date of Patent: April 17, 2001
    Assignee: Diagnostic Products Corporation
    Inventors: Cynthia K. French, Patrick A. Schneider, Karen K. Yamamoto
  • Patent number: 5807993
    Abstract: An autoantigen identified as HP-8 which is related to systemic lupus erythematosus. The HP-8 antigen is expressed by a gene which was identified by immunoscreening of human placental cDNA GT11 expression library with the monoclonal antibody 3E10. The 3E10 antibody is a low-affinity anti-double-stranded DNA autoantibody derived from the MRL murine models for human systemic lupus erythematosus.
    Type: Grant
    Filed: April 12, 1995
    Date of Patent: September 15, 1998
    Assignee: VivoRx Autoimmune, Inc.
    Inventors: Cynthia K. French, Karen K. Yamamoto, Phoebe M. Chow, Negemias T. Alido